Abstract

A key constraint to successfully commercializing beneficial microorganisms is overcoming difficulties in formulating a viable, cost-effective, and user-friendly final product. The live nature of the active ingredient (i.e., the microbial agent) underscores the importance of formulation in maintaining the microbial cells in a metabolically and physiologically competent state in order to obtain the desired benefit when applied. The development of new microbial formulations is a challenging task and requires greater effort in terms of funding and research towards making significant advances in this field.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call